BDNF and schizophrenia: After a 24-month olanzapine treatment (unspecified dose), 95 schizophrenic patients with metabolic syndrome showed lower concentrations of BDNF (P < 0.012) and higher values of TNF-α as compared to 121 patients only diagnosed with schizophrenia (218).